Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DarioHealth Corp. stock logo
DRIO
DarioHealth
$1.47
-2.0%
$1.61
$0.68
$4.58
$43.63M1.66134,578 shs44,445 shs
Dynatronics Co. stock logo
DYNT
Dynatronics
$0.58
-1.7%
$0.47
$0.37
$1.62
$2.81M0.45371,794 shs72,565 shs
LLIT
Lianluo Smart
$0.79
$9.91
$2.76
$17.14
$1.74M0.161.04 million shs117,181 shs
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
$0.18
+6.0%
$4.22
$0.66
$10.77
$1.78M-1.237.68 million shs172,531 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DarioHealth Corp. stock logo
DRIO
DarioHealth
+3.45%+23.97%+0.67%-27.88%-54.13%
Dynatronics Co. stock logo
DYNT
Dynatronics
+9.38%+0.82%+28.78%+15.49%-60.68%
LLIT
Lianluo Smart
+5.30%+10.76%-24.26%-1.50%-22.81%
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
-1.41%+2.50%-10.63%-17.23%-93.28%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
DarioHealth Corp. stock logo
DRIO
DarioHealth
1.597 of 5 stars
3.51.00.00.01.80.81.3
Dynatronics Co. stock logo
DYNT
Dynatronics
0.8505 of 5 stars
3.03.00.00.00.60.00.6
LLIT
Lianluo Smart
N/AN/AN/AN/AN/AN/AN/AN/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DarioHealth Corp. stock logo
DRIO
DarioHealth
3.00
Buy$5.37265.08% Upside
Dynatronics Co. stock logo
DYNT
Dynatronics
2.00
Hold$3.80560.41% Upside
LLIT
Lianluo Smart
N/AN/AN/AN/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
N/AN/AN/AN/A

Current Analyst Ratings

Latest OBLN, DYNT, LLIT, and DRIO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/1/2024
DarioHealth Corp. stock logo
DRIO
DarioHealth
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$4.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DarioHealth Corp. stock logo
DRIO
DarioHealth
$20.35M2.14N/AN/A$2.14 per share0.69
Dynatronics Co. stock logo
DYNT
Dynatronics
$40.61M0.07N/AN/A$2.19 per share0.26
LLIT
Lianluo Smart
$380K4.57N/AN/A($0.59) per share-1.33
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
$1.59M1.12N/AN/A$0.60 per share0.30

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DarioHealth Corp. stock logo
DRIO
DarioHealth
-$59.43M-$1.03N/AN/AN/A-165.96%-48.84%-31.56%5/9/2024 (Estimated)
Dynatronics Co. stock logo
DYNT
Dynatronics
-$4.97M-$1.38N/AN/A-14.13%-54.88%-16.14%5/9/2024 (Estimated)
LLIT
Lianluo Smart
-$4.45MN/A0.00N/AN/AN/AN/AN/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
-$12.33MN/AN/AN/A-776.76%-161.38%-83.58%N/A

Latest OBLN, DYNT, LLIT, and DRIO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
DarioHealth Corp. stock logo
DRIO
DarioHealth
-$0.54-$0.41+$0.13-$0.41$3.57 million$3.62 million
2/7/2024Q2 2024
Dynatronics Co. stock logo
DYNT
Dynatronics
N/A-$0.27-$0.27-$0.27N/A$8.15 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
DarioHealth Corp. stock logo
DRIO
DarioHealth
N/AN/AN/AN/AN/A
Dynatronics Co. stock logo
DYNT
Dynatronics
N/AN/AN/AN/AN/A
LLIT
Lianluo Smart
N/AN/AN/AN/AN/A
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DarioHealth Corp. stock logo
DRIO
DarioHealth
0.42
3.79
3.38
Dynatronics Co. stock logo
DYNT
Dynatronics
0.21
1.41
0.67
LLIT
Lianluo Smart
N/A
2.42
2.17
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
N/A
1.86
1.86

Ownership

Institutional Ownership

CompanyInstitutional Ownership
DarioHealth Corp. stock logo
DRIO
DarioHealth
33.39%
Dynatronics Co. stock logo
DYNT
Dynatronics
4.18%
LLIT
Lianluo Smart
28.75%
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
18.64%

Insider Ownership

CompanyInsider Ownership
DarioHealth Corp. stock logo
DRIO
DarioHealth
10.10%
Dynatronics Co. stock logo
DYNT
Dynatronics
9.10%
LLIT
Lianluo Smart
22.90%
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
8.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
DarioHealth Corp. stock logo
DRIO
DarioHealth
27629.68 million26.47 millionOptionable
Dynatronics Co. stock logo
DYNT
Dynatronics
1544.88 million4.44 millionNot Optionable
LLIT
Lianluo Smart
62.21 millionN/ANot Optionable
Obalon Therapeutics, Inc. stock logo
OBLN
Obalon Therapeutics
210.02 millionN/ANot Optionable

OBLN, DYNT, LLIT, and DRIO Headlines

SourceHeadline
Obalon Therapeutics, Inc.Obalon Therapeutics, Inc.
thestreet.com - February 25 at 12:23 PM
Spero Therapeutics Inc.Spero Therapeutics Inc.
wsj.com - February 6 at 3:31 PM
Intragastric Balloon Market Growth and Forecast till 2031Intragastric Balloon Market Growth and Forecast till 2031
marketwatch.com - March 28 at 11:39 PM
Intragastric Balloons Market to Grow with a Significant CAGR During the forecast period 2022-2028| Exclusive Report Spread Across 149 PagesIntragastric Balloons Market to Grow with a Significant CAGR During the forecast period 2022-2028| Exclusive Report Spread Across 149 Pages
marketwatch.com - August 17 at 9:10 PM
Renovare Environmental Inc (RENO)Renovare Environmental Inc (RENO)
investing.com - January 5 at 8:30 AM
Understanding Atara Biotherapeuticss Unusual Options ActivityUnderstanding Atara Biotherapeutics's Unusual Options Activity
benzinga.com - August 10 at 11:04 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

DarioHealth logo

DarioHealth

NASDAQ:DRIO
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
Dynatronics logo

Dynatronics

NASDAQ:DYNT
Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.

Lianluo Smart

NASDAQ:LLIT
Lianluo Smart Limited, together with its subsidiaries, designs, develops, markets, and distributes medical products primarily in China and internationally. The company offers medical devices, including wearable sleep respiratory solutions, general hospital products, medical compressors, and related supporting products. It also provides technical services in relation to the detection and analysis of obstructive sleep apnea syndrome to hospitals and medical centers through medical wearable devices. In addition, the company distributes medical products, such as sleep apnea machines. Lianluo Smart Limited sells its products primarily through distributors; and directly to hospitals, physical examination centers, and sleep centers, as well as to individual consumers. The company was formerly known as Dehaier Medical Systems Limited and changed its name to Lianluo Smart Limited in November 2016. Lianluo Smart Limited was incorporated in 2003 and is headquartered in Beijing, China.
Obalon Therapeutics logo

Obalon Therapeutics

NASDAQ:OBLN
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.